Concepts (201)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteomics | 7 | 2022 | 93 | 2.150 |
Why?
|
| Gene Expression Profiling | 6 | 2023 | 160 | 1.860 |
Why?
|
| Transcriptome | 8 | 2023 | 84 | 1.560 |
Why?
|
| Proteome | 5 | 2023 | 40 | 1.550 |
Why?
|
| RNA, Messenger | 3 | 2022 | 325 | 1.430 |
Why?
|
| Alzheimer Disease | 12 | 2023 | 2005 | 1.350 |
Why?
|
| Algorithms | 3 | 2023 | 401 | 1.240 |
Why?
|
| Cognitive Dysfunction | 8 | 2023 | 969 | 1.060 |
Why?
|
| Brain | 11 | 2023 | 1727 | 0.950 |
Why?
|
| Dementia | 3 | 2022 | 527 | 0.790 |
Why?
|
| Sjogren's Syndrome | 2 | 2020 | 4 | 0.770 |
Why?
|
| Multifactorial Inheritance | 1 | 2019 | 24 | 0.690 |
Why?
|
| Histones | 1 | 2019 | 28 | 0.690 |
Why?
|
| Blood Proteins | 1 | 2018 | 20 | 0.640 |
Why?
|
| Methotrexate | 1 | 2018 | 42 | 0.620 |
Why?
|
| ErbB Receptors | 2 | 2010 | 73 | 0.620 |
Why?
|
| Epigenomics | 1 | 2017 | 12 | 0.590 |
Why?
|
| Antirheumatic Agents | 1 | 2018 | 92 | 0.590 |
Why?
|
| Immunophenotyping | 1 | 2017 | 85 | 0.580 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2017 | 35 | 0.580 |
Why?
|
| Gene Regulatory Networks | 2 | 2015 | 33 | 0.580 |
Why?
|
| Genome-Wide Association Study | 4 | 2023 | 304 | 0.520 |
Why?
|
| Models, Genetic | 1 | 2015 | 36 | 0.500 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2018 | 364 | 0.480 |
Why?
|
| Humans | 28 | 2023 | 29851 | 0.390 |
Why?
|
| Aged | 13 | 2023 | 9621 | 0.380 |
Why?
|
| Phosphoproteins | 1 | 2010 | 28 | 0.370 |
Why?
|
| Amyloid beta-Peptides | 5 | 2023 | 302 | 0.320 |
Why?
|
| Models, Biological | 2 | 2010 | 347 | 0.310 |
Why?
|
| Aged, 80 and over | 10 | 2023 | 4930 | 0.310 |
Why?
|
| Cerebral Cortex | 2 | 2019 | 197 | 0.300 |
Why?
|
| Mass Spectrometry | 2 | 2022 | 41 | 0.300 |
Why?
|
| Male | 15 | 2023 | 15871 | 0.270 |
Why?
|
| Cognition | 5 | 2023 | 1314 | 0.270 |
Why?
|
| Prefrontal Cortex | 3 | 2023 | 153 | 0.260 |
Why?
|
| Female | 13 | 2023 | 16430 | 0.250 |
Why?
|
| Quantitative Trait Loci | 2 | 2021 | 60 | 0.240 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2023 | 446 | 0.240 |
Why?
|
| Cluster Analysis | 1 | 2023 | 53 | 0.230 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2023 | 4 | 0.230 |
Why?
|
| Benchmarking | 1 | 2023 | 42 | 0.230 |
Why?
|
| Phosphorylation | 4 | 2017 | 159 | 0.210 |
Why?
|
| Neurofibrillary Tangles | 2 | 2023 | 189 | 0.210 |
Why?
|
| Protein Biosynthesis | 1 | 2022 | 25 | 0.200 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2021 | 8 | 0.200 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2021 | 16 | 0.190 |
Why?
|
| Nervous System Diseases | 1 | 2023 | 149 | 0.190 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2020 | 6 | 0.180 |
Why?
|
| Schizophrenia | 2 | 2011 | 77 | 0.180 |
Why?
|
| Peptides | 1 | 2021 | 98 | 0.180 |
Why?
|
| tau Proteins | 4 | 2023 | 213 | 0.180 |
Why?
|
| Proteins | 1 | 2020 | 71 | 0.180 |
Why?
|
| Acetylation | 1 | 2019 | 13 | 0.170 |
Why?
|
| Adaptation, Psychological | 1 | 2020 | 142 | 0.170 |
Why?
|
| Psychomotor Performance | 1 | 2021 | 220 | 0.170 |
Why?
|
| Gene Expression Regulation | 2 | 2018 | 285 | 0.170 |
Why?
|
| Movement Disorders | 1 | 2021 | 148 | 0.170 |
Why?
|
| Parkinsonian Disorders | 1 | 2023 | 222 | 0.170 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2019 | 27 | 0.170 |
Why?
|
| MicroRNAs | 1 | 2019 | 44 | 0.170 |
Why?
|
| Pyrimidines | 2 | 2017 | 28 | 0.160 |
Why?
|
| Sleep Deprivation | 1 | 2019 | 64 | 0.160 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2018 | 5 | 0.160 |
Why?
|
| Infliximab | 1 | 2018 | 16 | 0.160 |
Why?
|
| Up-Regulation | 1 | 2019 | 174 | 0.160 |
Why?
|
| Seasons | 1 | 2018 | 31 | 0.160 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 14 | 0.160 |
Why?
|
| Cell Count | 1 | 2018 | 97 | 0.160 |
Why?
|
| Remission Induction | 1 | 2018 | 103 | 0.160 |
Why?
|
| Genotype | 1 | 2019 | 408 | 0.160 |
Why?
|
| Neuropsychological Tests | 2 | 2019 | 1270 | 0.160 |
Why?
|
| Lymphocytes | 1 | 2018 | 110 | 0.150 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2019 | 118 | 0.150 |
Why?
|
| Independent Living | 1 | 2020 | 285 | 0.150 |
Why?
|
| Monocytes | 1 | 2018 | 111 | 0.150 |
Why?
|
| Phenotype | 3 | 2023 | 364 | 0.150 |
Why?
|
| Neutrophils | 1 | 2018 | 118 | 0.150 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2018 | 119 | 0.150 |
Why?
|
| Computational Biology | 1 | 2017 | 24 | 0.150 |
Why?
|
| Computer Simulation | 2 | 2010 | 219 | 0.150 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2017 | 21 | 0.140 |
Why?
|
| Alternative Splicing | 1 | 2017 | 25 | 0.140 |
Why?
|
| RNA-Binding Proteins | 1 | 2017 | 24 | 0.140 |
Why?
|
| ADAM Proteins | 1 | 2017 | 65 | 0.140 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 55 | 0.140 |
Why?
|
| Chicago | 1 | 2019 | 867 | 0.140 |
Why?
|
| Case-Control Studies | 1 | 2018 | 643 | 0.140 |
Why?
|
| Imidazoles | 1 | 2017 | 72 | 0.140 |
Why?
|
| Motor Activity | 1 | 2019 | 372 | 0.140 |
Why?
|
| Signal Transduction | 2 | 2010 | 491 | 0.130 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2017 | 174 | 0.130 |
Why?
|
| Gene Expression | 3 | 2023 | 232 | 0.130 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1462 | 0.130 |
Why?
|
| Markov Chains | 1 | 2015 | 29 | 0.130 |
Why?
|
| Bayes Theorem | 1 | 2015 | 39 | 0.120 |
Why?
|
| Monte Carlo Method | 1 | 2015 | 53 | 0.120 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2011 | 59 | 0.120 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 1126 | 0.120 |
Why?
|
| Parkinson Disease | 1 | 2023 | 1184 | 0.110 |
Why?
|
| Epidermal Growth Factor | 2 | 2010 | 32 | 0.110 |
Why?
|
| Risk Factors | 1 | 2019 | 2467 | 0.110 |
Why?
|
| Cognition Disorders | 1 | 2019 | 1032 | 0.100 |
Why?
|
| Sequence Analysis, RNA | 2 | 2023 | 43 | 0.100 |
Why?
|
| Aging | 2 | 2019 | 1630 | 0.100 |
Why?
|
| Tyrosine | 1 | 2010 | 25 | 0.090 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 26 | 0.090 |
Why?
|
| Twins, Monozygotic | 1 | 2010 | 7 | 0.090 |
Why?
|
| Chromatography, Liquid | 1 | 2010 | 25 | 0.090 |
Why?
|
| DNA Copy Number Variations | 1 | 2010 | 10 | 0.090 |
Why?
|
| Diseases in Twins | 1 | 2010 | 8 | 0.090 |
Why?
|
| Adult | 3 | 2023 | 8748 | 0.090 |
Why?
|
| Linear Models | 2 | 2023 | 258 | 0.090 |
Why?
|
| Blotting, Western | 1 | 2010 | 175 | 0.090 |
Why?
|
| Middle Aged | 4 | 2018 | 9963 | 0.090 |
Why?
|
| Cell Line | 1 | 2010 | 299 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2021 | 307 | 0.090 |
Why?
|
| Treatment Outcome | 1 | 2018 | 3561 | 0.080 |
Why?
|
| Cohort Studies | 3 | 2019 | 1953 | 0.080 |
Why?
|
| Phosphotyrosine | 1 | 2008 | 1 | 0.080 |
Why?
|
| Mutation | 1 | 2010 | 399 | 0.080 |
Why?
|
| Autopsy | 2 | 2019 | 338 | 0.080 |
Why?
|
| Animals | 2 | 2019 | 4639 | 0.070 |
Why?
|
| Neurons | 2 | 2021 | 381 | 0.070 |
Why?
|
| Computer Graphics | 1 | 2006 | 5 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 2 | 2020 | 176 | 0.070 |
Why?
|
| Software | 1 | 2006 | 72 | 0.070 |
Why?
|
| Kinetics | 1 | 2006 | 230 | 0.060 |
Why?
|
| Molecular Biology | 1 | 2023 | 14 | 0.060 |
Why?
|
| Base Sequence | 1 | 2023 | 135 | 0.060 |
Why?
|
| DNA | 1 | 2023 | 123 | 0.060 |
Why?
|
| Organ Size | 1 | 2023 | 107 | 0.060 |
Why?
|
| Protein Aggregates | 1 | 2023 | 7 | 0.060 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2023 | 14 | 0.060 |
Why?
|
| Adaptor Protein Complex 1 | 1 | 2023 | 5 | 0.060 |
Why?
|
| Adaptor Protein Complex beta Subunits | 1 | 2023 | 5 | 0.060 |
Why?
|
| RNA | 1 | 2023 | 40 | 0.050 |
Why?
|
| Nerve Growth Factors | 1 | 2023 | 49 | 0.050 |
Why?
|
| Mitochondria | 1 | 2023 | 84 | 0.050 |
Why?
|
| Neuropathology | 1 | 2023 | 81 | 0.050 |
Why?
|
| Receptors, Estrogen | 1 | 2023 | 68 | 0.050 |
Why?
|
| Alleles | 1 | 2021 | 225 | 0.050 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2020 | 5 | 0.050 |
Why?
|
| Actinin | 1 | 2020 | 7 | 0.050 |
Why?
|
| Vesicular Transport Proteins | 1 | 2020 | 9 | 0.050 |
Why?
|
| Epoxide Hydrolases | 1 | 2020 | 10 | 0.050 |
Why?
|
| GPI-Linked Proteins | 1 | 2020 | 26 | 0.050 |
Why?
|
| Molecular Chaperones | 1 | 2020 | 13 | 0.050 |
Why?
|
| Neuropeptides | 1 | 2020 | 30 | 0.050 |
Why?
|
| SOXC Transcription Factors | 1 | 2020 | 1 | 0.050 |
Why?
|
| Germinal Center | 1 | 2020 | 2 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 56 | 0.050 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2020 | 42 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 78 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2020 | 87 | 0.040 |
Why?
|
| Thy-1 Antigens | 1 | 2019 | 2 | 0.040 |
Why?
|
| Sensory Gating | 1 | 2019 | 3 | 0.040 |
Why?
|
| Exploratory Behavior | 1 | 2019 | 18 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2019 | 81 | 0.040 |
Why?
|
| Schizophrenic Psychology | 1 | 2019 | 26 | 0.040 |
Why?
|
| Sclerosis | 1 | 2019 | 68 | 0.040 |
Why?
|
| Nerve Net | 1 | 2019 | 54 | 0.040 |
Why?
|
| Microglia | 1 | 2019 | 125 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 256 | 0.040 |
Why?
|
| Plaque, Amyloid | 1 | 2019 | 146 | 0.040 |
Why?
|
| Neuroimaging | 1 | 2019 | 138 | 0.040 |
Why?
|
| Neural Stem Cells | 1 | 2018 | 14 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2019 | 128 | 0.040 |
Why?
|
| Cognitive Aging | 1 | 2019 | 81 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 411 | 0.040 |
Why?
|
| Memory, Episodic | 1 | 2019 | 120 | 0.040 |
Why?
|
| Sleep Wake Disorders | 1 | 2019 | 148 | 0.040 |
Why?
|
| Genetic Association Studies | 1 | 2018 | 86 | 0.040 |
Why?
|
| Lewy Bodies | 1 | 2019 | 198 | 0.040 |
Why?
|
| Memory | 1 | 2019 | 323 | 0.040 |
Why?
|
| TDP-43 Proteinopathies | 1 | 2019 | 105 | 0.040 |
Why?
|
| Apolipoprotein E4 | 1 | 2019 | 233 | 0.040 |
Why?
|
| Logistic Models | 1 | 2018 | 410 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2017 | 10 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2017 | 43 | 0.040 |
Why?
|
| Exons | 1 | 2017 | 38 | 0.040 |
Why?
|
| Hippocampus | 1 | 2019 | 285 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 65 | 0.040 |
Why?
|
| Astrocytes | 1 | 2018 | 122 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2017 | 107 | 0.040 |
Why?
|
| Genome, Human | 1 | 2017 | 49 | 0.040 |
Why?
|
| Sleep | 1 | 2019 | 318 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 332 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 744 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 1824 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 970 | 0.030 |
Why?
|
| Biomarkers | 1 | 2018 | 704 | 0.030 |
Why?
|
| Mice | 1 | 2019 | 1628 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 1247 | 0.030 |
Why?
|
| Coenzyme A Ligases | 1 | 2011 | 5 | 0.020 |
Why?
|
| Homozygote | 1 | 2011 | 22 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2010 | 24 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 166 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2010 | 75 | 0.020 |
Why?
|
| src-Family Kinases | 1 | 2008 | 8 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 273 | 0.020 |
Why?
|
| Time Factors | 1 | 2008 | 1641 | 0.010 |
Why?
|